基本信息：

出生年月：1995.10.18

常用邮箱：zhoulisha@126.com

教育经历：

2014.9-2019.6 天津医科大学临床医学院  医学检验技术 学士

2019.9-2022.6 石河子大学  免疫学  硕士

2022.9-至今 南京大学 药学 博士

论文发表情况：

1. Jie Pan#, Lisha Zhou#, Chenyang Zhang, Qiang Xu, Yang Sun*. Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy. Signal Transduct Target Ther 2022; 7:177.

2. Lisha Zhou, Wang M, Guo H, Hou J, Zhang Y, Li M, Wu X, Chen X, Wang L. Integrated Analysis Highlights the Immunosuppressive Role of TREM2+ Macrophages in Hepatocellular Carcinoma. Front Immunol. 2022 Mar 14;13: 848367.

3. Guoliang Deng#, Lisha Zhou#, Binglin Wang#, Xiaofan Sun, Hongqi Chen, Dongdong Sun*, Yang Sun*, Haibo Cheng*. Targeting cathepsin B by cycloastragenol enhances anti-tumor immunity via inhibiting MHC-1 degradation and promoting the presentation of tumor antigen. Journal for ImmunoTherapy of Cancer 2022, in press.

4. Wang L, Zhou L, Hou J, Meng J, Lin K, Wu X, Chen X. Three novel circRNAs upregulated in tissue and plasma from hepatocellular carcinoma patients and their regulatory network. Cancer Cell Int. 2021 Jan 22;21(1):72.

5. Zhang Y, Yang X, Zhou L, Gao X, Wu X, Chen X, Hou J, Wang L. Immune-related lincRNA pairs predict prognosis and therapeutic response in hepatocellular carcinoma. Sci Rep. 2022 Mar 11;12(1):4259.

6. Nan H, Zhou L, Liang W, Meng J, Lin K, Li M, Hou J, Wang L. Epigenetically associated CCL20 upregulation correlates with esophageal cancer progression and immune disorder. Pathol Res Pract. 2021 Dec; 228:153683.